Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer
Clinical trial NCT02768415 · UNKNOWN
Trial details
- NCT number
- NCT02768415
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.